Arcturus Therapeutics Ltd. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Arcturus Therapeutics Ltd. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $7.00 million for the 12-month period ending 2017-12-31, per its 20-F filed 2018-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2018-05-14
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|
| 2017-12-31 | $7.00M 20-F · filed 2018-05-14 |
| 2015-12-31 | $1.90M 20-F · filed 2018-05-14 |